Abg Wtt Global Life Science Capital Partners Gp LTD Pulmonx Corp Transaction History
Abg Wtt Global Life Science Capital Partners Gp LTD
- $1.34 Million
- Q4 2024
A detailed history of Abg Wtt Global Life Science Capital Partners Gp LTD transactions in Pulmonx Corp stock. As of the latest transaction made, Abg Wtt Global Life Science Capital Partners Gp LTD holds 60,204 shares of LUNG stock, worth $539,427. This represents 30.4% of its overall portfolio holdings.
Number of Shares
60,204
Previous 60,204
-0.0%
Holding current value
$539,427
Previous $499,000
18.24%
% of portfolio
30.4%
Previous 35.07%
Shares
3 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$49.4 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$27.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$23.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$20.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$13.8 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $334M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...